Has Wall Street Given Up On Oracle Stock Too Soon?

Wall Street seems to be having a complicated relationship with Oracle lately, treating the tech giant like a laggard despite fundamentals that suggest otherwise. Over the past year, Oracle’s stock has plummeted by 38 percent, marking the worst performance among its primary competitors. What makes this trend puzzling is that the company still commands a rich valuation, trading at 24.4 times earnings. This puts it well above rivals like Alphabet, creating a strange paradox where investors are paying a premium for a stock that they are simultaneously fleeing.

On paper, Oracle looks like a powerhouse. Its operating margins and revenue growth remain highly competitive, trailing only Microsoft in several key efficiency metrics. However, the market appears less interested in current stability and more concerned about the massive gamble Oracle is taking on artificial intelligence. The company is currently staring down a staggering 638 billion dollar backlog of contracted work, providing an unusual level of transparency into future sales and promising aggressive growth through 2027.

The catch is the astronomical cost of fulfilling those promises. To build out the necessary cloud infrastructure and data centers, Oracle expects a net cash outlay of approximately 70 billion dollars by fiscal 2027, necessitating another 40 billion dollars in new debt and equity. Investors are understandably jittery about this spending spree and management’s warning that gross margins will likely dip as these facilities ramp up operations. Essentially, Wall Street is questioning if the price of entry into the AI race is simply too expensive.

The tension between potential rewards and immediate risks will come to a head next quarter. With forecasted revenue growth expected between 27 and 29 percent, shareholders are looking for concrete proof that these heavy investments are translating into actual income. Whether the market has given up on Oracle too soon or correctly spotted a looming crisis depends entirely on whether the company can hit those ambitious targets in the coming months.